You just read:

Xynomic Pharma Achieves Important Regulatory Milestones in China and EU in Potentially Pivotal Kidney Cancer and Lymphoma Trials

News provided by

Xynomic Pharmaceuticals, Inc.

Mar 16, 2019, 03:04 ET